The Latest Cardiac and Vascular News
SUZHOU, China, Jan. 19, 2022 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in-licensing agreement with JenaValve Technology, Inc. Under the terms of the agreement, Peijia has made a cash and equity investment in JenaValve and will commit additional capital based upon development milestones in […]
VANCOUVER and MINNEAPOLIS, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicine describing successful uses of the Neovasc Reducer™ (“Reducer”) under a compassionate use protocol in the United States. The patients were treated under the care […]
CHICAGO, Jan. 17, 2022 (GLOBE NEWSWIRE) — Today, Dr. Nathan S. Bryan, world-renowned molecular medicine and nitric oxide expert and founder of Pneuma Nitric Oxide, LLC and Bryan Nitriceuticals, LLC, announced a partnership with Berkeley Life, a practitioner-exclusive nitric oxide nutraceutical brand. Dr. Bryan and Berkeley Life share a mission […]
Two novel targets identified through the existing collaboration have already been added to AstraZeneca’s portfolio LONDON, Jan. 13, 2022 /PRNewswire/ — BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas being explored through the partnership. The three-year expansion includes an […]
NDA submitted for sotagliflozin in heart failure with an expected launch in 2H 2022, if approved LX9211 neuropathic pain Phase 2 studies expected to read out in 1H 2022 THE WOODLANDS, Texas, Jan. 13, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) is outlining major potential value drivers for 2022 at […]
Perceval Sutureless Aortic Heart Valve Received Approval in China to Treat Patients with Aortic Valve Disease LONDON–(BUSINESS WIRE)–CORCYM, the medical device company dedicated to providing patients and cardiac surgeons with the best solutions to fight structural heart disease, announces today the first Perceval implant in China, after the recent approval from the […]
Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039, Exclusive of Any Possible Extensions MORRISVILLE, N.C., Jan. 12, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that […]
Helping patients stick with their care plans and accurately communicate with their providers key to the best quality of life possible, says heart failure nurse specialist PORTLAND, Maine–(BUSINESS WIRE)–A heart failure nurse specialist saw a need for her patients to track the specific metrics needed for their physical well-being, empowering […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the successful results of the first-in-human early feasibility study of the preCARDIA system. The preCARDIA system is designed to improve decongestion in acutely decompensated heart failure (ADHF) patients by intermittently occluding the superior vena cava. The results of the study published this week in the […]
Most Recent Pre-Clinical Trial Explored Placement in Arterial Branches Seeing Significant Results ISRAEL, Jan. 11, 2022 /PRNewswire/ — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, today announced a major milestone in ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS) in Israel. Following three […]
